McKesson Corporation Income Statement
MCK / Health Care|15 years of annual SEC 10-K data (FY2012-FY2026)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Revenue has grown at a 9.6% compound annual rate over the past 13 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | $403.4B | $359.1B | $238.2B | $231.1B | $214.3B | $208.4B | $198.5B | $190.9B | $179.0B | $198.5B | $122.2B | $179.0B | $137.4B | $122.2B |
| Cost of Revenue | - | $388.9B | $345.7B | $226.1B | $219.0B | $202.6B | $197.2B | $187.3B | $179.5B | $167.6B | $187.3B | $115.3B | $167.6B | $129.0B | $115.3B |
| Gross Profit | - | $14.6B | $13.3B | $12.1B | $12.0B | $11.8B | $11.2B | $11.3B | $11.4B | $11.4B | $11.3B | $6.9B | $11.4B | $8.4B | $6.9B |
| SG&A Expense | - | $8.1B | $8.5B | $8.8B | $9.2B | $8.4B | $8.1B | $7.4B | $7.4B | $7.9B | $7.4B | $4.1B | $7.9B | $5.4B | $4.1B |
| R&D Expense | - | - | - | - | - | - | $125.0M | $341.0M | $392.0M | $392.0M | $341.0M | $433.0M | $392.0M | $457.0M | $433.0M |
| Operating Income | - | $6.2B | $4.4B | -$5.0B | $2.5B | $886.0M | $762.0M | $7.1B | $3.5B | $3.0B | $7.1B | $2.3B | $3.0B | $2.4B | $2.3B |
| Interest Expense | - | - | - | $217.0M | $249.0M | $264.0M | $283.0M | - | - | - | - | - | - | - | - |
| Income Tax | - | $1.1B | $878.0M | -$695.0M | $18.0M | $356.0M | -$53.0M | $1.6B | $908.0M | $815.0M | $1.6B | $587.0M | $815.0M | $757.0M | $587.0M |
| Net Income | - | $4.8B | $3.3B | -$4.5B | $900.0M | $34.0M | $67.0M | $5.1B | $2.3B | $1.5B | $5.1B | $1.3B | $1.5B | $1.3B | $1.3B |
| EPS (Basic) | $22.54 | $25.23 | $7.32 | -$28.26 | $4.98 | $0.17 | $0.32 | $22.95 | $9.82 | $6.37 | $5.51 | $5.71 | $6.37 | $5.51 | $5.71 |
| EPS (Diluted) | $22.39 | $25.03 | $7.23 | -$28.26 | $4.95 | $0.17 | $0.32 | $22.73 | $9.70 | $6.27 | $5.41 | $5.59 | $6.27 | $5.41 | $5.59 |
| Shares Outstanding | 134.1M | 142.2M | 154.1M | 160.6M | 181.6M | 197.3M | 209.0M | 223.0M | 233.0M | 235.0M | 233.0M | 239.0M | 235.0M | 233.0M | 239.0M |
| Gross Margin | - | 3.6% | 3.7% | 5.1% | 5.2% | 5.5% | 5.4% | 5.7% | 6.0% | 6.4% | 5.7% | 5.6% | 6.4% | 6.1% | 5.6% |
| Operating Margin | - | 1.5% | 1.2% | -2.1% | 1.1% | 0.4% | 0.4% | 3.6% | 1.9% | 1.7% | 3.6% | 1.9% | 1.7% | 1.8% | 1.9% |
| Profit Margin | - | 1.2% | 0.9% | -1.9% | 0.4% | 0.0% | 0.0% | 2.5% | 1.2% | 0.8% | 2.5% | 1.1% | 0.8% | 0.9% | 1.1% |